---------gloss--------
(0) Xinhua News Agency , Beijing , January 16th , by reporter Ye Yuan 
(1) [1m[33m{China 's}[0m pharmaceutical enterprises , which mainly produce large amount of medicines used as raw materials and imitate foreign chemical medicines over a long period of time , will accelerate the development of new medicines and technologies with [1m[31m{their}[0m own intellectual property rights . 
(2) [34m{An official from the State Pharmaceutical Administration Bureau}[0m said that , starting [35m{this year}[0m , financial aid for the research of innovative medicines will be further increased , and State - owned funds would give investment priority to the fields of high technology and innovated medical products . 
(3) [35m{This year}[0m , [36m{the State Pharmaceutical Administration Bureau}[0m will evaluate and decide the top 50 enterprises in the pharmaceutical industry according to new criteria . 
(4) Total annual sales revenue is predicted to be more than 60 % of [1m[33m{the whole country 's}[0m medicine sales revenue . 
(5) At the same time , 3 - 5 % of each enterprise 's annual sales revenue will be used for the research and development of new medicines . 
(6) [34m{This official}[0m said that , at the same time , the State should also guide foreign capital to invest in new technologies , new products and medicine projects in the Midwest area , to give impetus to national medicine enterprises to improve products ' technical content and enhance competitiveness in the international market . 
(7) [1m[33m{China}[0m now has about 3,500 pharmaceutical enterprises , which produce 1,350 kinds of medicines used as raw materials and 4,000 kinds of Chinese herbal medicines each year , and is the second largest producing and exporting country of medicines used as raw materials , second only to [1m[32m{America}[0m . 
(8) But due to science and technology content being low , the product 's sales price on the international market is 20 - 30 % lower than the normal price , and can only return more than 1 billion US dollars in foreign currency each year . 
(9) While in 1996 , importing pharmaceutical preparations alone consumed funds surpassing 1.1 billion US dollars in [1m[33m{China}[0m . 
(10) Now , in [1m[33m{China}[0m , there are less than 3,000 full time personnel engaging in the research of innovated medicines , only corresponding to personnel on the regular payroll of the research department of Merck Pharmaceutical Company of [1m[32m{the US}[0m . 
(11) Experts urge that [1m[33m{China 's}[0m pharmaceutical industry should change methods of focusing on the production of medicines used as raw materials , while paying less attention to development of preparations , and catching up with development trends of the global pharmaceutical industry as soon as possible . 
(12) It was learned that , the national project of new medicines and industrialized development , jointly promoted by departments of the State Science Commission , the Ministry of Public Health , [36m{the State Pharmaceutical Administration Bureau}[0m , etc. , is now being implemented . 
(13) By the end of this century , ten new patent protected medicines are planned to be developed and five new medicine selecting centers , five medication safety assessing centers and five medication clinic experimentation centers will be built . 
(14) -LRB- End -RRB- 
(end gloss)
---------document--------
(nw/xinhua/01/chtb_0121); part 000
sentences:
XinhuaXinhuaNNPORGPER0NewsNewsNNPORGPER0AgencyAgencyNNPORGPER0,,,OPER0BeijingBeijingNNPGPEPER0,,,OPER0JanuaryJanuaryNNPDATEPER016th16thNNDATEPER0,,,OPER0bybyINOPER0reporterreporterNNOPER0YeYeNNPORGPER0YuanYuanNNPORGPER0(ROOT (FRAG (NP (NNP Xinhua) (NNP News) (NNP Agency)) (, ,) (NP (NNP Beijing)) (, ,) (NP (NNP January) (NN 16th)) (, ,) (PP (IN by) (NP (NN reporter) (NNP Ye) (NNP Yuan)))))
ChinaChinaNNPGPEPER0's'sPOSOPER0pharmaceuticalpharmaceuticalJJOPER0enterprisesenterpriseNNSOPER0,,,OPER0whichwhichWDTOPER0mainlymainlyRBOPER0produceproduceVBPOPER0largelargeJJOPER0amountamountNNOPER0ofofINOPER0medicinesmedicineNNSOPER0useduseVBNOPER0asasINOPER0rawrawJJOPER0materialsmaterialNNSOPER0andandCCOPER0imitateimitateVBPOPER0foreignforeignJJOPER0chemicalchemicalNNOPER0medicinesmedicineNNSOPER0overoverINOPER0aaDTOPER0longlongJJOPER0periodperiodNNOPER0ofofINOPER0timetimeNNOPER0,,,OPER0willwillMDOPER0accelerateaccelerateVBOPER0thetheDTOPER0developmentdevelopmentNNOPER0ofofINOPER0newnewJJOPER0medicinesmedicineNNSOPER0andandCCOPER0technologiestechnologyNNSOPER0withwithINOPER0theirtheyPRP$OPER0ownownJJOPER0intellectualintellectualJJOPER0propertypropertyNNOPER0rightsrightsNNSOPER0...OPER0(ROOT (S (NP (NP (NP (NNP China) (POS 's)) (JJ pharmaceutical) (NNS enterprises)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB mainly)) (VP (VP (VBP produce) (NP (NP (JJ large) (NN amount)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials)))))))) (CC and) (VP (VBP imitate) (NP (JJ foreign) (NN chemical) (NNS medicines)) (PP (IN over) (NP (NP (DT a) (JJ long) (NN period)) (PP (IN of) (NP (NN time))))))))) (, ,)) (VP (MD will) (VP (VB accelerate) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ new) (NNS medicines) (CC and) (NNS technologies)))) (PP (IN with) (NP (PRP$ their) (JJ own) (NML (NML (JJ intellectual) (NN property)) (NNS rights)))))) (. .)))
AnaDTOPER0officialofficialNNOPER0fromfromINOPER0thetheDTORGPER0StateStateNNPORGPER0PharmaceuticalPharmaceuticalNNPORGPER0AdministrationAdministrationNNPORGPER0BureauBureauNNPORGPER0saidsayVBDOPER0thatthatINOPER0,,,OPER0startingstartVBGOPER0thisthisDTDATEPER0yearyearNNDATEPER0,,,OPER0financialfinancialJJOPER0aidaidNNOPER0forforINOPER0thetheDTOPER0researchresearchNNOPER0ofofINOPER0innovativeinnovativeJJOPER0medicinesmedicineNNSOPER0willwillMDOPER0bebeVBOPER0furtherfurtherRBOPER0increasedincreaseVBNOPER0,,,OPER0andandCCOPER0StatestateNNORGPER0--HYPHOPER0ownedownVBNOPER0fundsfundNNSOPER0wouldwouldMDOPER0givegiveVBOPER0investmentinvestmentNNOPER0prioritypriorityNNOPER0totoINOPER0thetheDTOPER0fieldsfieldNNSOPER0ofofINOPER0highhighJJOPER0technologytechnologyNNOPER0andandCCOPER0innovatedinnovateVBNOPER0medicalmedicalJJOPER0productsproductNNSOPER0...OPER0(ROOT (S (NP (NP (DT An) (NN official)) (PP (IN from) (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau)))) (VP (VBD said) (SBAR (IN that) (, ,) (S (S (S (VP (VBG starting) (NP (DT this) (NN year)))) (, ,) (NP (NP (JJ financial) (NN aid)) (PP (IN for) (NP (NP (DT the) (NN research)) (PP (IN of) (NP (JJ innovative) (NNS medicines)))))) (VP (MD will) (VP (VB be) (ADVP (RB further)) (VP (VBN increased))))) (, ,) (CC and) (S (NP (ADJP (NN State) (HYPH -) (VBN owned)) (NNS funds)) (VP (MD would) (VP (VB give) (NP (NN investment) (NN priority)) (PP (IN to) (NP (NP (DT the) (NNS fields)) (PP (IN of) (NP (NP (JJ high) (NN technology)) (CC and) (NP (VBN innovated) (JJ medical) (NNS products)))))))))))) (. .)))
ThisthisDTDATEPER0yearyearNNDATEPER0,,,OPER0thetheDTORGPER0StateStateNNPORGPER0PharmaceuticalPharmaceuticalNNPORGPER0AdministrationAdministrationNNPORGPER0BureauBureauNNPORGPER0willwillMDOPER0evaluateevaluateVBOPER0andandCCOPER0decidedecideVBOPER0thetheDTOPER0toptopJJOPER05050CDCARDINALPER0enterprisesenterpriseNNSOPER0ininINOPER0thetheDTOPER0pharmaceuticalpharmaceuticalNNOPER0industryindustryNNOPER0accordingaccordVBGOPER0totoINOPER0newnewJJOPER0criteriacriterionNNSOPER0...OPER0(ROOT (S (NP (DT This) (NN year)) (, ,) (NP (DT the) (NNP State) (NNP Pharmaceutical) (NNP Administration) (NNP Bureau)) (VP (MD will) (VP (VB evaluate) (CC and) (VB decide) (NP (NP (DT the) (JJ top) (CD 50) (NNS enterprises)) (PP (IN in) (NP (DT the) (NN pharmaceutical) (NN industry)))) (PP (VBG according) (PP (IN to) (NP (JJ new) (NNS criteria)))))) (. .)))
TotaltotalJJOPER0annualannualJJOPER0salessaleNNSOPER0revenuerevenueNNOPER0isbeVBZOPER0predictedpredictVBNOPER0totoTOOPER0bebeVBOPER0moremoreJJRPERCENTPER0thanthanINPERCENTPER06060CDPERCENTPER0%%NNPERCENTPER0ofofINOPER0thetheDTOPER0wholewholeJJOPER0countrycountryNNOPER0's'sPOSOPER0medicinemedicineNNOPER0salessaleNNSOPER0revenuerevenueNNOPER0...OPER0(ROOT (S (NP (JJ Total) (JJ annual) (NNS sales) (NN revenue)) (VP (VBZ is) (VP (VBN predicted) (S (VP (TO to) (VP (VB be) (NP (NP (QP (XS (JJR more) (IN than)) (CD 60)) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ whole) (NN country) (POS 's)) (NN medicine) (NNS sales) (NN revenue))))))))) (. .)))
AtatINOPER0thetheDTOPER0samesameJJOPER0timetimeNNOPER0,,,OPER033CDCARDINALPER0--HYPHOPER055CDPERCENTPER0%%NNPERCENTPER0ofofINOPER0eacheachDTOPER0enterpriseenterpriseNNOPER0's'sPOSOPER0annualannualJJOPER0salessaleNNSOPER0revenuerevenueNNOPER0willwillMDOPER0bebeVBOPER0useduseVBNOPER0forforINOPER0thetheDTOPER0researchresearchNNOPER0andandCCOPER0developmentdevelopmentNNOPER0ofofINOPER0newnewJJOPER0medicinesmedicineNNSOPER0...OPER0(ROOT (S (PP (IN At) (NP (DT the) (JJ same) (NN time))) (, ,) (NP (NP (QP (CD 3) (HYPH -) (CD 5)) (NN %)) (PP (IN of) (NP (NP (DT each) (NN enterprise) (POS 's)) (JJ annual) (NNS sales) (NN revenue)))) (VP (MD will) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (DT the) (NN research) (CC and) (NN development)) (PP (IN of) (NP (JJ new) (NNS medicines)))))))) (. .)))
ThisthisDTOPER0officialofficialNNOPER0saidsayVBDOPER0thatthatINOPER0,,,OPER0atatINOPER0thetheDTOPER0samesameJJOPER0timetimeNNOPER0,,,OPER0thetheDTOPER0StatestateNNORGPER0shouldshouldMDOPER0alsoalsoRBOPER0guideguideVBOPER0foreignforeignJJOPER0capitalcapitalNNOPER0totoTOOPER0investinvestVBOPER0ininINOPER0newnewJJOPER0technologiestechnologyNNSOPER0,,,OPER0newnewJJOPER0productsproductNNSOPER0andandCCOPER0medicinemedicineNNOPER0projectsprojectNNSOPER0ininINOPER0thetheDTOPER0MidwestMidwestNNPLOCPER0areaareaNNOPER0,,,OPER0totoTOOPER0givegiveVBOPER0impetusimpetusNNOPER0totoINOPER0nationalnationalJJOPER0medicinemedicineNNOPER0enterprisesenterpriseNNSOPER0totoTOOPER0improveimproveVBOPER0productsproductNNSOPER0''POSOPER0technicaltechnicalJJOPER0contentcontentNNOPER0andandCCOPER0enhanceenhanceVBOPER0competitivenesscompetitivenessNNOPER0ininINOPER0thetheDTOPER0internationalinternationalJJOPER0marketmarketNNOPER0...OPER0(ROOT (S (NP (DT This) (NN official)) (VP (VBD said) (SBAR (IN that) (, ,) (S (PP (IN at) (NP (DT the) (JJ same) (NN time))) (, ,) (NP (DT the) (NN State)) (VP (MD should) (ADVP (RB also)) (VP (VB guide) (NP (JJ foreign) (NN capital)) (S (VP (TO to) (VP (VB invest) (PP (IN in) (NP (NP (JJ new) (NNS technologies)) (, ,) (NP (JJ new) (NNS products)) (CC and) (NP (NN medicine) (NNS projects)))) (PP (IN in) (NP (DT the) (NNP Midwest) (NN area)))))) (, ,) (S (VP (TO to) (VP (VB give) (NP (NN impetus)) (PP (IN to) (NP (NP (JJ national) (NN medicine) (NNS enterprises)) (SBAR (S (VP (TO to) (VP (VP (VB improve) (NP (NP (NNS products) (POS ')) (JJ technical) (NN content))) (CC and) (VP (VB enhance) (NP (NN competitiveness)) (PP (IN in) (NP (DT the) (JJ international) (NN market)))))))))))))))))) (. .)))
ChinaChinaNNPGPEPER0nownowRBOPER0hashaveVBZOPER0aboutaboutRBCARDINALPER03,5003,500CDCARDINALPER0pharmaceuticalpharmaceuticalJJOPER0enterprisesenterpriseNNSOPER0,,,OPER0whichwhichWDTOPER0produceproduceVBPOPER01,3501,350CDCARDINALPER0kindskindNNSOPER0ofofINOPER0medicinesmedicineNNSOPER0useduseVBNOPER0asasINOPER0rawrawJJOPER0materialsmaterialNNSOPER0andandCCOPER04,0004,000CDCARDINALPER0kindskindNNSOPER0ofofINOPER0ChinesechineseJJOPER0herbalherbalJJOPER0medicinesmedicineNNSOPER0eacheachDTOPER0yearyearNNOPER0,,,OPER0andandCCOPER0isbeVBZOPER0thetheDTOPER0secondsecondJJORDINALPER0largestlargestJJSOPER0producingproduceVBGOPER0andandCCOPER0exportingexportVBGOPER0countrycountryNNOPER0ofofINOPER0medicinesmedicineNNSOPER0useduseVBNOPER0asasINOPER0rawrawJJOPER0materialsmaterialNNSOPER0,,,OPER0secondsecondRBOPER0onlyonlyRBOPER0totoINOPER0AmericaAmericaNNPGPEPER0...OPER0(ROOT (S (NP (NNP China)) (ADVP (RB now)) (VP (VP (VBZ has) (NP (NP (QP (RB about) (CD 3,500)) (JJ pharmaceutical) (NNS enterprises)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP produce) (NP (NP (CD 1,350) (NNS kinds)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (CC and) (NP (NP (CD 4,000) (NNS kinds)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS medicines)))))) (NP (DT each) (NN year))))))))))) (, ,) (CC and) (VP (VBZ is) (NP (NP (NP (DT the) (JJ second) (JJS largest) (VBG producing)) (CC and) (NP (VBG exporting) (NN country))) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (, ,) (ADVP (RB second) (RB only) (PP (IN to) (NP (NNP America)))))))))))) (. .)))
ButbutCCOPER0duedueJJOPER0totoINOPER0sciencescienceNNOPER0andandCCOPER0technologytechnologyNNOPER0contentcontentNNOPER0beingbeVBGOPER0lowlowJJOPER0,,,OPER0thetheDTOPER0productproductNNOPER0's'sPOSOPER0salessaleNNSOPER0pricepriceNNOPER0ononINOPER0thetheDTOPER0internationalinternationalJJOPER0marketmarketNNOPER0isbeVBZOPER02020CDPERCENTPER0--HYPHPERCENTPER03030CDPERCENTPER0%%NNPERCENTPER0lowerlowerJJROPER0thanthanINOPER0thetheDTOPER0normalnormalJJOPER0pricepriceNNOPER0,,,OPER0andandCCOPER0cancanMDOPER0onlyonlyRBOPER0returnreturnVBOPER0moremoreJJRMONEYPER0thanthanINMONEYPER011CDMONEYPER0billionbillionCDMONEYPER0USUSNNPMONEYPER0dollarsdollarNNSMONEYPER0ininINOPER0foreignforeignJJOPER0currencycurrencyNNOPER0eacheachDTOPER0yearyearNNOPER0...OPER0(ROOT (S (CC But) (S (NP (ADJP (JJ due) (PP (IN to) (NP (NN science) (CC and) (NN technology)))) (NN content)) (VP (VBG being) (ADJP (JJ low)))) (, ,) (NP (NP (NP (DT the) (NN product) (POS 's)) (NNS sales) (NN price)) (PP (IN on) (NP (DT the) (JJ international) (NN market)))) (VP (VP (VBZ is) (ADJP (ADJP (NML (QP (CD 20) (HYPH -) (CD 30)) (NN %)) (JJR lower)) (PP (IN than) (NP (DT the) (JJ normal) (NN price))))) (, ,) (CC and) (VP (MD can) (ADVP (RB only)) (VP (VB return) (NP (NP (NP (QP (XS (JJR more) (IN than)) (CD 1) (CD billion)) (NNP US) (NNS dollars)) (PP (IN in) (NP (JJ foreign) (NN currency)))) (NP (DT each) (NN year)))))) (. .)))
WhilewhileINOPER0ininINOPER019961996CDDATEPER0,,,OPER0importingimportVBGOPER0pharmaceuticalpharmaceuticalJJOPER0preparationspreparationNNSOPER0alonealoneRBOPER0consumedconsumeVBNOPER0fundsfundNNSOPER0surpassingsurpassVBGOPER01.11.1CDMONEYPER0billionbillionCDMONEYPER0USUSNNPMONEYPER0dollarsdollarNNSMONEYPER0ininINOPER0ChinaChinaNNPGPEPER0...OPER0(ROOT (S (SBAR (IN While) (S (PP (IN in) (NP (CD 1996))) (, ,) (VP (VBG importing) (NP (JJ pharmaceutical) (NNS preparations))))) (ADVP (RB alone)) (VP (VBN consumed) (NP (NP (NNS funds)) (VP (VBG surpassing) (NP (QP (CD 1.1) (CD billion)) (NNP US) (NNS dollars)))) (PP (IN in) (NP (NNP China)))) (. .)))
NownowRBOPER0,,,OPER0ininINOPER0ChinaChinaNNPGPEPER0,,,OPER0therethereEXOPER0arebeVBPOPER0lesslessJJRCARDINALPER0thanthanINCARDINALPER03,0003,000CDCARDINALPER0fullfullJJOPER0timetimeNNOPER0personnelpersonnelNNSOPER0engagingengageVBGOPER0ininINOPER0thetheDTOPER0researchresearchNNOPER0ofofINOPER0innovatedinnovatedJJOPER0medicinesmedicineNNSOPER0,,,OPER0onlyonlyRBOPER0correspondingcorrespondVBGOPER0totoINOPER0personnelpersonnelNNSOPER0ononINOPER0thetheDTOPER0regularregularJJOPER0payrollpayrollNNOPER0ofofINOPER0thetheDTOPER0researchresearchNNOPER0departmentdepartmentNNOPER0ofofINOPER0MerckMerckNNPORGPER0PharmaceuticalPharmaceuticalNNPORGPER0CompanyCompanyNNPORGPER0ofofINOPER0thetheDTOPER0USUSNNPGPEPER0...OPER0(ROOT (S (ADVP (RB Now)) (, ,) (PP (IN in) (NP (NNP China))) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (QP (XS (JJR less) (IN than)) (CD 3,000)) (NML (JJ full) (NN time)) (NNS personnel)) (VP (VBG engaging) (PP (IN in) (NP (NP (DT the) (NN research)) (PP (IN of) (NP (JJ innovated) (NNS medicines))))))) (, ,) (PP (ADVP (RB only)) (VBG corresponding) (PP (IN to) (NP (NP (NNS personnel)) (PP (IN on) (NP (NP (DT the) (JJ regular) (NN payroll)) (PP (IN of) (NP (NP (DT the) (NN research) (NN department)) (PP (IN of) (NP (NP (NNP Merck) (NNP Pharmaceutical) (NNP Company)) (PP (IN of) (NP (DT the) (NNP US))))))))))))) (. .)))
ExpertsexpertNNSOPER0urgeurgeVBPOPER0thatthatINOPER0ChinaChinaNNPGPEPER0's'sPOSOPER0pharmaceuticalpharmaceuticalNNOPER0industryindustryNNOPER0shouldshouldMDOPER0changechangeVBOPER0methodsmethodNNSOPER0ofofINOPER0focusingfocusVBGOPER0ononINOPER0thetheDTOPER0productionproductionNNOPER0ofofINOPER0medicinesmedicineNNSOPER0useduseVBNOPER0asasINOPER0rawrawJJOPER0materialsmaterialNNSOPER0,,,OPER0whilewhileINOPER0payingpayVBGOPER0lesslessJJROPER0attentionattentionNNOPER0totoINOPER0developmentdevelopmentNNOPER0ofofINOPER0preparationspreparationNNSOPER0,,,OPER0andandCCOPER0catchingcatchVBGOPER0upupRPOPER0withwithINOPER0developmentdevelopmentNNOPER0trendstrendNNSOPER0ofofINOPER0thetheDTOPER0globalglobalJJOPER0pharmaceuticalpharmaceuticalNNOPER0industryindustryNNOPER0asasRBOPER0soonsoonRBOPER0asasINOPER0possiblepossibleJJOPER0...OPER0(ROOT (S (NP (NNS Experts)) (VP (VBP urge) (SBAR (IN that) (S (NP (NP (NNP China) (POS 's)) (NN pharmaceutical) (NN industry)) (VP (MD should) (VP (VB change) (NP (NP (NNS methods)) (PP (IN of) (S (VP (VBG focusing) (PP (IN on) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials)))))))))))))))) (, ,) (SBAR (IN while) (S (S (VP (VBG paying) (NP (NP (JJR less) (NN attention)) (PP (IN to) (NP (NP (NN development)) (PP (IN of) (NP (NNS preparations)))))))) (, ,) (CC and) (S (VP (VBG catching) (PRT (RP up)) (PP (IN with) (NP (NP (NN development) (NNS trends)) (PP (IN of) (NP (DT the) (JJ global) (NN pharmaceutical) (NN industry))))) (ADVP (ADVP (RB as) (RB soon)) (PP (IN as) (ADJP (JJ possible))))))))) (. .)))
ItitPRPOPER0wasbeVBDOPER0learnedlearnVBNOPER0thatthatINOPER0,,,OPER0thetheDTOPER0nationalnationalJJOPER0projectprojectNNOPER0ofofINOPER0newnewJJOPER0medicinesmedicineNNSOPER0andandCCOPER0industrializedindustrializedJJOPER0developmentdevelopmentNNOPER0,,,OPER0jointlyjointlyRBOPER0promotedpromoteVBNOPER0bybyINOPER0departmentsdepartmentNNSOPER0ofofINOPER0thetheDTORGPER0StateStateNNPORGPER0ScienceScienceNNPORGPER0CommissionCommissionNNPORGPER0,,,OPER0thetheDTORGPER0MinistryMinistryNNPORGPER0ofofINORGPER0PublicPublicNNPORGPER0HealthHealthNNPORGPER0,,,OPER0thetheDTORGPER0StateStateNNPORGPER0PharmaceuticalPharmaceuticalNNPORGPER0AdministrationAdministrationNNPORGPER0BureauBureauNNPORGPER0,,,OPER0etc.etc.FWOPER0,,,OPER0isbeVBZOPER0nownowRBOPER0beingbeVBGOPER0implementedimplementVBNOPER0...OPER0(ROOT (S (NP (PRP It)) (VP (VBD was) (VP (VBN learned) (SBAR (IN that) (, ,) (S (NP (NP (NP (DT the) (JJ national) (NN project)) (PP (IN of) (NP (NP (JJ new) (NNS medicines)) (CC and) (NP (JJ industrialized) (NN development))))) (, ,) (VP (ADVP (RB jointly)) (VBN promoted) (PP (IN by) (NP (NP (NNS departments)) (PP (IN of) (NP (NP (DT the) (NNP State) (NNP Science) (NNP Commission)) (, ,) (NP (NP (DT the) (NNP Ministry)) (PP (IN of) (NP (NNP Public) (NNP Health)))) (, ,) (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau)) (, ,) (ADVP (FW etc.))))))) (, ,)) (VP (VBZ is) (ADVP (RB now)) (VP (VBG being) (VP (VBN implemented)))))))) (. .)))
BybyINOPER0thetheDTDATEPER0endendNNDATEPER0ofofINDATEPER0thisthisDTDATEPER0centurycenturyNNDATEPER0,,,OPER0tentenCDCARDINALPER0newnewJJOPER0patentpatentNNOPER0protectedprotectVBNOPER0medicinesmedicineNNSOPER0arebeVBPOPER0plannedplanVBNOPER0totoTOOPER0bebeVBOPER0developeddevelopVBNOPER0andandCCOPER0fivefiveCDCARDINALPER0newnewJJOPER0medicinemedicineNNOPER0selectingselectVBGOPER0centerscenterNNSOPER0,,,OPER0fivefiveCDCARDINALPER0medicationmedicationNNOPER0safetysafetyNNOPER0assessingassessVBGOPER0centerscenterNNSOPER0andandCCOPER0fivefiveCDCARDINALPER0medicationmedicationNNOPER0clinicclinicNNOPER0experimentationexperimentationNNOPER0centerscenterNNSOPER0willwillMDOPER0bebeVBOPER0builtbuildVBNOPER0...OPER0(ROOT (S (S (PP (IN By) (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT this) (NN century))))) (, ,) (NP (CD ten) (JJ new) (ADJP (NN patent) (VBN protected)) (NNS medicines)) (VP (VBP are) (VP (VBN planned) (S (VP (TO to) (VP (VB be) (VP (VBN developed)))))))) (CC and) (S (NP (NP (CD five) (JJ new) (ADJP (NN medicine) (VBG selecting)) (NNS centers)) (, ,) (NP (CD five) (NML (NN medication) (NN safety) (VBG assessing)) (NNS centers)) (CC and) (NP (CD five) (NML (NN medication) (NN clinic)) (NN experimentation) (NNS centers))) (VP (MD will) (VP (VB be) (VP (VBN built))))) (. .)))
-LRB--lrb--LRB-OPER0EndendNNORGPER0-RRB--rrb--RRB-OPER0(ROOT (NP (-LRB- -LRB-) (NN End) (-RRB- -RRB-)))
<end>
(end document)
---------gold mentions--------
sid=1 spanning 0 until 4 headed by 3 parsed as (NP (NP (NP (NNP China) (POS 's)) (JJ pharmaceutical) (NNS enterprises)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB mainly)) (VP (VP (VBP produce) (NP (NP (JJ large) (NN amount)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials)))))))) (CC and) (VP (VBP imitate) (NP (JJ foreign) (NN chemical) (NNS medicines)) (PP (IN over) (NP (NP (DT a) (JJ long) (NN period)) (PP (IN of) (NP (NN time))))))))) (, ,))
sid=1 spanning 0 until 2 headed by 0 parsed as (NP (NNP China) (POS 's))
sid=1 spanning 38 until 39 headed by 38 parsed as their
sid=2 spanning 0 until 8 headed by 1 parsed as (NP (NP (DT An) (NN official)) (PP (IN from) (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau))))
sid=2 spanning 3 until 8 headed by 7 parsed as (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau))
sid=2 spanning 12 until 14 headed by 13 parsed as (NP (DT this) (NN year))
sid=3 spanning 0 until 2 headed by 1 parsed as (NP (DT This) (NN year))
sid=3 spanning 3 until 8 headed by 7 parsed as (NP (DT the) (NNP State) (NNP Pharmaceutical) (NNP Administration) (NNP Bureau))
sid=4 spanning 13 until 17 headed by 15 parsed as (NP (DT the) (JJ whole) (NN country) (POS 's))
sid=6 spanning 0 until 2 headed by 1 parsed as (NP (DT This) (NN official))
sid=7 spanning 0 until 1 headed by 0 parsed as (NP (NNP China))
sid=7 spanning 47 until 48 headed by 47 parsed as (NP (NNP America))
sid=9 spanning 16 until 17 headed by 16 parsed as (NP (NNP China))
sid=10 spanning 3 until 4 headed by 3 parsed as (NP (NNP China))
sid=10 spanning 38 until 40 headed by 39 parsed as (NP (DT the) (NNP US))
sid=11 spanning 3 until 7 headed by 6 parsed as (NP (NP (NNP China) (POS 's)) (NN pharmaceutical) (NN industry))
sid=11 spanning 3 until 5 headed by 3 parsed as (NP (NNP China) (POS 's))
sid=12 spanning 31 until 36 headed by 35 parsed as (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau))
(end gold mentions)
---------predicted mentions--------
sid=0 spanning 0 until 3 headed by 2 parsed as (NP (NNP Xinhua) (NNP News) (NNP Agency))
sid=0 spanning 4 until 5 headed by 4 parsed as (NP (NNP Beijing))
sid=0 spanning 6 until 8 headed by 7 parsed as (NP (NNP January) (NN 16th))
sid=0 spanning 10 until 13 headed by 12 parsed as (NP (NN reporter) (NNP Ye) (NNP Yuan))
sid=1 spanning 0 until 28 headed by 3 parsed as (NP (NP (NP (NNP China) (POS 's)) (JJ pharmaceutical) (NNS enterprises)) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (RB mainly)) (VP (VP (VBP produce) (NP (NP (JJ large) (NN amount)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials)))))))) (CC and) (VP (VBP imitate) (NP (JJ foreign) (NN chemical) (NNS medicines)) (PP (IN over) (NP (NP (DT a) (JJ long) (NN period)) (PP (IN of) (NP (NN time))))))))) (, ,))
sid=1 spanning 0 until 4 headed by 3 parsed as (NP (NP (NNP China) (POS 's)) (JJ pharmaceutical) (NNS enterprises))
sid=1 spanning 0 until 2 headed by 0 parsed as (NP (NNP China) (POS 's))
sid=1 spanning 14 until 16 headed by 15 parsed as (NP (JJ raw) (NNS materials))
sid=1 spanning 18 until 21 headed by 20 parsed as (NP (JJ foreign) (NN chemical) (NNS medicines))
sid=1 spanning 22 until 27 headed by 24 parsed as (NP (NP (DT a) (JJ long) (NN period)) (PP (IN of) (NP (NN time))))
sid=1 spanning 26 until 27 headed by 26 parsed as (NP (NN time))
sid=1 spanning 30 until 37 headed by 31 parsed as (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ new) (NNS medicines) (CC and) (NNS technologies))))
sid=1 spanning 33 until 37 headed by 34 parsed as (NP (JJ new) (NNS medicines) (CC and) (NNS technologies))
sid=1 spanning 38 until 43 headed by 42 parsed as (NP (PRP$ their) (JJ own) (NML (NML (JJ intellectual) (NN property)) (NNS rights)))
sid=1 spanning 38 until 39 headed by 38 parsed as (PRP$ their)
sid=2 spanning 0 until 8 headed by 1 parsed as (NP (NP (DT An) (NN official)) (PP (IN from) (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau))))
sid=2 spanning 3 until 8 headed by 7 parsed as (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau))
sid=2 spanning 12 until 14 headed by 13 parsed as (NP (DT this) (NN year))
sid=2 spanning 18 until 23 headed by 19 parsed as (NP (NP (DT the) (NN research)) (PP (IN of) (NP (JJ innovative) (NNS medicines))))
sid=2 spanning 21 until 23 headed by 22 parsed as (NP (JJ innovative) (NNS medicines))
sid=2 spanning 29 until 33 headed by 32 parsed as (NP (ADJP (NN State) (HYPH -) (VBN owned)) (NNS funds))
sid=2 spanning 35 until 37 headed by 36 parsed as (NP (NN investment) (NN priority))
sid=2 spanning 38 until 47 headed by 39 parsed as (NP (NP (DT the) (NNS fields)) (PP (IN of) (NP (NP (JJ high) (NN technology)) (CC and) (NP (VBN innovated) (JJ medical) (NNS products)))))
sid=2 spanning 44 until 47 headed by 46 parsed as (NP (VBN innovated) (JJ medical) (NNS products))
sid=3 spanning 0 until 2 headed by 1 parsed as (NP (DT This) (NN year))
sid=3 spanning 3 until 8 headed by 7 parsed as (NP (DT the) (NNP State) (NNP Pharmaceutical) (NNP Administration) (NNP Bureau))
sid=3 spanning 12 until 20 headed by 15 parsed as (NP (NP (DT the) (JJ top) (CD 50) (NNS enterprises)) (PP (IN in) (NP (DT the) (NN pharmaceutical) (NN industry))))
sid=3 spanning 17 until 20 headed by 19 parsed as (NP (DT the) (NN pharmaceutical) (NN industry))
sid=3 spanning 22 until 24 headed by 23 parsed as (NP (JJ new) (NNS criteria))
sid=4 spanning 13 until 20 headed by 19 parsed as (NP (NP (DT the) (JJ whole) (NN country) (POS 's)) (NN medicine) (NNS sales) (NN revenue))
sid=4 spanning 13 until 17 headed by 15 parsed as (NP (DT the) (JJ whole) (NN country) (POS 's))
sid=5 spanning 1 until 4 headed by 3 parsed as (NP (DT the) (JJ same) (NN time))
sid=5 spanning 10 until 16 headed by 15 parsed as (NP (NP (DT each) (NN enterprise) (POS 's)) (JJ annual) (NNS sales) (NN revenue))
sid=5 spanning 10 until 13 headed by 11 parsed as (NP (DT each) (NN enterprise) (POS 's))
sid=5 spanning 20 until 27 headed by 21 parsed as (NP (NP (DT the) (NN research) (CC and) (NN development)) (PP (IN of) (NP (JJ new) (NNS medicines))))
sid=5 spanning 25 until 27 headed by 26 parsed as (NP (JJ new) (NNS medicines))
sid=6 spanning 0 until 2 headed by 1 parsed as (NP (DT This) (NN official))
sid=6 spanning 6 until 9 headed by 8 parsed as (NP (DT the) (JJ same) (NN time))
sid=6 spanning 10 until 12 headed by 11 parsed as (NP (DT the) (NN State))
sid=6 spanning 20 until 28 headed by 21 parsed as (NP (NP (JJ new) (NNS technologies)) (, ,) (NP (JJ new) (NNS products)) (CC and) (NP (NN medicine) (NNS projects)))
sid=6 spanning 20 until 22 headed by 21 parsed as (NP (JJ new) (NNS technologies))
sid=6 spanning 23 until 25 headed by 24 parsed as (NP (JJ new) (NNS products))
sid=6 spanning 26 until 28 headed by 27 parsed as (NP (NN medicine) (NNS projects))
sid=6 spanning 29 until 32 headed by 31 parsed as (NP (DT the) (NNP Midwest) (NN area))
sid=6 spanning 30 until 31 headed by 30 parsed as Midwest
sid=6 spanning 37 until 53 headed by 39 parsed as (NP (NP (JJ national) (NN medicine) (NNS enterprises)) (SBAR (S (VP (TO to) (VP (VP (VB improve) (NP (NP (NNS products) (POS ')) (JJ technical) (NN content))) (CC and) (VP (VB enhance) (NP (NN competitiveness)) (PP (IN in) (NP (DT the) (JJ international) (NN market)))))))))
sid=6 spanning 42 until 46 headed by 45 parsed as (NP (NP (NNS products) (POS ')) (JJ technical) (NN content))
sid=6 spanning 42 until 44 headed by 42 parsed as (NP (NNS products) (POS '))
sid=6 spanning 50 until 53 headed by 52 parsed as (NP (DT the) (JJ international) (NN market))
sid=7 spanning 0 until 1 headed by 0 parsed as (NP (NNP China))
sid=7 spanning 3 until 27 headed by 6 parsed as (NP (NP (QP (RB about) (CD 3,500)) (JJ pharmaceutical) (NNS enterprises)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP produce) (NP (NP (CD 1,350) (NNS kinds)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (CC and) (NP (NP (CD 4,000) (NNS kinds)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS medicines)))))) (NP (DT each) (NN year))))))))))
sid=7 spanning 3 until 7 headed by 6 parsed as (NP (QP (RB about) (CD 3,500)) (JJ pharmaceutical) (NNS enterprises))
sid=7 spanning 10 until 27 headed by 11 parsed as (NP (NP (CD 1,350) (NNS kinds)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (CC and) (NP (NP (CD 4,000) (NNS kinds)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS medicines)))))) (NP (DT each) (NN year))))))
sid=7 spanning 13 until 27 headed by 13 parsed as (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (CC and) (NP (NP (CD 4,000) (NNS kinds)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS medicines)))))) (NP (DT each) (NN year))))
sid=7 spanning 16 until 25 headed by 17 parsed as (NP (NP (JJ raw) (NNS materials)) (CC and) (NP (NP (CD 4,000) (NNS kinds)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS medicines)))))
sid=7 spanning 16 until 18 headed by 17 parsed as (NP (JJ raw) (NNS materials))
sid=7 spanning 19 until 25 headed by 20 parsed as (NP (NP (CD 4,000) (NNS kinds)) (PP (IN of) (NP (JJ Chinese) (JJ herbal) (NNS medicines))))
sid=7 spanning 22 until 25 headed by 24 parsed as (NP (JJ Chinese) (JJ herbal) (NNS medicines))
sid=7 spanning 25 until 27 headed by 26 parsed as (NP (DT each) (NN year))
sid=7 spanning 30 until 48 headed by 32 parsed as (NP (NP (NP (DT the) (JJ second) (JJS largest) (VBG producing)) (CC and) (NP (VBG exporting) (NN country))) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (, ,) (ADVP (RB second) (RB only) (PP (IN to) (NP (NNP America))))))))))
sid=7 spanning 30 until 34 headed by 32 parsed as (NP (DT the) (JJ second) (JJS largest) (VBG producing))
sid=7 spanning 31 until 32 headed by 31 parsed as second
sid=7 spanning 35 until 37 headed by 36 parsed as (NP (VBG exporting) (NN country))
sid=7 spanning 38 until 48 headed by 38 parsed as (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (NP (JJ raw) (NNS materials)) (, ,) (ADVP (RB second) (RB only) (PP (IN to) (NP (NNP America))))))))
sid=7 spanning 41 until 48 headed by 42 parsed as (NP (NP (JJ raw) (NNS materials)) (, ,) (ADVP (RB second) (RB only) (PP (IN to) (NP (NNP America)))))
sid=7 spanning 41 until 43 headed by 42 parsed as (NP (JJ raw) (NNS materials))
sid=7 spanning 47 until 48 headed by 47 parsed as (NP (NNP America))
sid=8 spanning 3 until 6 headed by 3 parsed as (NP (NN science) (CC and) (NN technology))
sid=8 spanning 10 until 19 headed by 14 parsed as (NP (NP (NP (DT the) (NN product) (POS 's)) (NNS sales) (NN price)) (PP (IN on) (NP (DT the) (JJ international) (NN market))))
sid=8 spanning 10 until 13 headed by 11 parsed as (NP (DT the) (NN product) (POS 's))
sid=8 spanning 16 until 19 headed by 18 parsed as (NP (DT the) (JJ international) (NN market))
sid=8 spanning 26 until 29 headed by 28 parsed as (NP (DT the) (JJ normal) (NN price))
sid=8 spanning 43 until 45 headed by 44 parsed as (NP (DT each) (NN year))
sid=9 spanning 2 until 3 headed by 2 parsed as (NP (CD 1996))
sid=9 spanning 5 until 7 headed by 6 parsed as (NP (JJ pharmaceutical) (NNS preparations))
sid=9 spanning 9 until 15 headed by 9 parsed as (NP (NP (NNS funds)) (VP (VBG surpassing) (NP (QP (CD 1.1) (CD billion)) (NNP US) (NNS dollars))))
sid=9 spanning 16 until 17 headed by 16 parsed as (NP (NNP China))
sid=10 spanning 3 until 4 headed by 3 parsed as (NP (NNP China))
sid=10 spanning 7 until 20 headed by 12 parsed as (NP (NP (QP (XS (JJR less) (IN than)) (CD 3,000)) (NML (JJ full) (NN time)) (NNS personnel)) (VP (VBG engaging) (PP (IN in) (NP (NP (DT the) (NN research)) (PP (IN of) (NP (JJ innovated) (NNS medicines)))))))
sid=10 spanning 15 until 20 headed by 16 parsed as (NP (NP (DT the) (NN research)) (PP (IN of) (NP (JJ innovated) (NNS medicines))))
sid=10 spanning 18 until 20 headed by 19 parsed as (NP (JJ innovated) (NNS medicines))
sid=10 spanning 24 until 40 headed by 24 parsed as (NP (NP (NNS personnel)) (PP (IN on) (NP (NP (DT the) (JJ regular) (NN payroll)) (PP (IN of) (NP (NP (DT the) (NN research) (NN department)) (PP (IN of) (NP (NP (NNP Merck) (NNP Pharmaceutical) (NNP Company)) (PP (IN of) (NP (DT the) (NNP US))))))))))
sid=10 spanning 26 until 40 headed by 28 parsed as (NP (NP (DT the) (JJ regular) (NN payroll)) (PP (IN of) (NP (NP (DT the) (NN research) (NN department)) (PP (IN of) (NP (NP (NNP Merck) (NNP Pharmaceutical) (NNP Company)) (PP (IN of) (NP (DT the) (NNP US))))))))
sid=10 spanning 30 until 40 headed by 32 parsed as (NP (NP (DT the) (NN research) (NN department)) (PP (IN of) (NP (NP (NNP Merck) (NNP Pharmaceutical) (NNP Company)) (PP (IN of) (NP (DT the) (NNP US))))))
sid=10 spanning 34 until 40 headed by 36 parsed as (NP (NP (NNP Merck) (NNP Pharmaceutical) (NNP Company)) (PP (IN of) (NP (DT the) (NNP US))))
sid=10 spanning 38 until 40 headed by 39 parsed as (NP (DT the) (NNP US))
sid=11 spanning 0 until 1 headed by 0 parsed as (NP (NNS Experts))
sid=11 spanning 3 until 7 headed by 6 parsed as (NP (NP (NNP China) (POS 's)) (NN pharmaceutical) (NN industry))
sid=11 spanning 3 until 5 headed by 3 parsed as (NP (NNP China) (POS 's))
sid=11 spanning 9 until 21 headed by 9 parsed as (NP (NP (NNS methods)) (PP (IN of) (S (VP (VBG focusing) (PP (IN on) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials))))))))))))
sid=11 spanning 13 until 21 headed by 14 parsed as (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials)))))))
sid=11 spanning 16 until 21 headed by 16 parsed as (NP (NP (NNS medicines)) (VP (VBN used) (PP (IN as) (NP (JJ raw) (NNS materials)))))
sid=11 spanning 19 until 21 headed by 20 parsed as (NP (JJ raw) (NNS materials))
sid=11 spanning 24 until 30 headed by 25 parsed as (NP (NP (JJR less) (NN attention)) (PP (IN to) (NP (NP (NN development)) (PP (IN of) (NP (NNS preparations))))))
sid=11 spanning 27 until 30 headed by 27 parsed as (NP (NP (NN development)) (PP (IN of) (NP (NNS preparations))))
sid=11 spanning 29 until 30 headed by 29 parsed as (NP (NNS preparations))
sid=11 spanning 35 until 42 headed by 36 parsed as (NP (NP (NN development) (NNS trends)) (PP (IN of) (NP (DT the) (JJ global) (NN pharmaceutical) (NN industry))))
sid=11 spanning 38 until 42 headed by 41 parsed as (NP (DT the) (JJ global) (NN pharmaceutical) (NN industry))
sid=12 spanning 5 until 39 headed by 7 parsed as (NP (NP (NP (DT the) (JJ national) (NN project)) (PP (IN of) (NP (NP (JJ new) (NNS medicines)) (CC and) (NP (JJ industrialized) (NN development))))) (, ,) (VP (ADVP (RB jointly)) (VBN promoted) (PP (IN by) (NP (NP (NNS departments)) (PP (IN of) (NP (NP (DT the) (NNP State) (NNP Science) (NNP Commission)) (, ,) (NP (NP (DT the) (NNP Ministry)) (PP (IN of) (NP (NNP Public) (NNP Health)))) (, ,) (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau)) (, ,) (ADVP (FW etc.))))))) (, ,))
sid=12 spanning 5 until 14 headed by 7 parsed as (NP (NP (DT the) (JJ national) (NN project)) (PP (IN of) (NP (NP (JJ new) (NNS medicines)) (CC and) (NP (JJ industrialized) (NN development)))))
sid=12 spanning 9 until 14 headed by 10 parsed as (NP (NP (JJ new) (NNS medicines)) (CC and) (NP (JJ industrialized) (NN development)))
sid=12 spanning 9 until 11 headed by 10 parsed as (NP (JJ new) (NNS medicines))
sid=12 spanning 18 until 19 headed by 18 parsed as (NP (NNS departments))
sid=12 spanning 20 until 24 headed by 23 parsed as (NP (NP (DT the) (NNP State) (NNP Science) (NNP Commission)) (, ,) (NP (NP (DT the) (NNP Ministry)) (PP (IN of) (NP (NNP Public) (NNP Health)))) (, ,) (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau)) (, ,) (ADVP (FW etc.)))
sid=12 spanning 25 until 30 headed by 26 parsed as (NP (NP (DT the) (NNP Ministry)) (PP (IN of) (NP (NNP Public) (NNP Health))))
sid=12 spanning 31 until 36 headed by 35 parsed as (NP (DT the) (NNP State) (NML (NNP Pharmaceutical) (NNP Administration)) (NNP Bureau))
sid=13 spanning 1 until 6 headed by 2 parsed as (NP (NP (DT the) (NN end)) (PP (IN of) (NP (DT this) (NN century))))
sid=13 spanning 7 until 12 headed by 11 parsed as (NP (CD ten) (JJ new) (ADJP (NN patent) (VBN protected)) (NNS medicines))
sid=13 spanning 18 until 35 headed by 22 parsed as (NP (NP (CD five) (JJ new) (ADJP (NN medicine) (VBG selecting)) (NNS centers)) (, ,) (NP (CD five) (NML (NN medication) (NN safety) (VBG assessing)) (NNS centers)) (CC and) (NP (CD five) (NML (NN medication) (NN clinic)) (NN experimentation) (NNS centers)))
sid=13 spanning 18 until 23 headed by 22 parsed as (NP (CD five) (JJ new) (ADJP (NN medicine) (VBG selecting)) (NNS centers))
sid=13 spanning 24 until 29 headed by 28 parsed as (NP (CD five) (NML (NN medication) (NN safety) (VBG assessing)) (NNS centers))
sid=13 spanning 30 until 35 headed by 34 parsed as (NP (CD five) (NML (NN medication) (NN clinic)) (NN experimentation) (NNS centers))
sid=14 spanning 0 until 3 headed by 1 parsed as (NP (-LRB- -LRB-) (NN End) (-RRB- -RRB-))
(end predicted mentions)
---------gold clusters--------
3 9 | { 'An official from the State Pharmaceutical Administration Bureau' 'This official' }
5 6 | { 'this year' 'This year' }
4 17 7 | { 'the State Pharmaceutical Administration Bureau' 'the State Pharmaceutical Administration Bureau' 'the State Pharmaceutical Administration Bureau' }
0 15 2 | { 'China 's pharmaceutical enterprises' 'China 's pharmaceutical industry' 'their' }
14 11 | { 'the US' 'America' }
1 10 16 13 8 12 | { 'China 's' 'China' 'China 's' 'China' 'the whole country 's' 'China' }
(end gold clusters)